Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Broad Center for Mendelian Genomics, |
RCV003226099 | SCV003922246 | likely pathogenic | Multiple mitochondrial dysfunctions syndrome 6 | 2023-05-02 | criteria provided, single submitter | curation | The heterozygous p.Glu181AspfsTer5 variant in PMPCB was identified by our study, in the compound heterozygous state with a likely pathogenic variant (ClinVar Variation ID: 523138), in one individual with multiple mitochondrial dysfunction syndrome 6. Trio exome analysis revealed this variant to be in trans with a likely pathogenic variant (ClinVar Variation ID: 523138). The p.Glu181AspfsTer5 variant in PMPCB has not been previously reported in individuals with multiple mitochondrial dysfunction syndrome 6. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 181 and leads to a premature termination codon 5 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the PMPCB gene is strongly associated to autosomal recessive multiple mitochondrial dysfunction syndrome 6. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive multiple mitochondrial dysfunction syndrome 6. ACMG/AMP Criteria applied: PVS1_Strong, PM2_Supporting, PM3 (Richards 2015). |